Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Regenerated fully functional hair follicles using stem cells, with potential for hair regrowth therapy.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Testosterone's muscle-building effects do not require its conversion to DHT.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

The herbal extract SHJ promotes hair growth and increases melanin production.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

Some supplements and hormones can increase hair loss by raising DHT levels.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.